Conexeu Sciences Inc. (CNXU) — Stock Valuation & Research

Conexeu Sciences Inc. specializes in pioneering regenerative biomaterials intended for various medical fields, including wound management, dental practices, and aesthetic medicine. The enterprise began operations on November 2, 2022, co-founded by Claudia Chavez-Munoz, David R. Bogart, and Ryan Hartwell, and operates from its primary office in Reno, Nevada.

CNXU key statistics

Price$4.98
Market cap$133.26M
SectorHealthcare
IndustryBiotechnology
ExchangeNASDAQ
52-week range4.19-18.79
Beta0.51

Explore CNXU's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.